All articles in “Healthcare & Lifesciences”

11. January 2019
Healthcare & Lifesciences

On Tuesday, the Indian Supreme Court restored Bayer AG's Monsanto patent claim on genetically modified Bt cotton for the time being, thereby overturning a judgment to the contrary in April 2018. Until the Delhi Supreme Court decides on the validity of the patent, Monsanto may charge royalties on Bt cotton in India.

read more
10. January 2019
Healthcare & Lifesciences

The Hennigsdorf-based medical device manufacturer B-R-A-H-M-S GmbH has lost the German part of its European patent for the diagnosis of inflammation in parts. The plaintiffs can lodge a security deposit and thereby provisionally enforce the judgement - despite Brahms' possible appeal against the judgement.

read more
13. December 2018
Healthcare & Lifesciences

A supplementary protection certificate cannot be granted for a medicinal product which is protected by the basic patent and placed on the market - even if the product is a new formulation of an "old" active substance. The Advocate General recommends it today in an important SPC preliminary ruling in the Abraxis and Abraxan cases.

read more
7. December 2018
Healthcare & Lifesciences

Patents on plants and animals from conventional breeding have become more likely since this week. In a hearing before the Board of Appeal of the European Patent Office on the Syngenta patent on wild pepper, a far-reaching decision war announced.

read more
21. November 2018
Healthcare & Lifesciences

Pharmaceutical company Roche Italia is allowed to market off-label drugs without a marketing authorisation, the ECJ ruled today. The focus is on the drug Avastin, which is used not only for its approved indication for tumour diseases, but also as an off-label treatment for eye diseases.

read more
20. November 2018
Healthcare & Lifesciences

The European Patent Office (EPO) has revoked Bayer AG's controversial Monsanto biopatent, which was intended to protect the breeding of broccoli to facilitate harvesting. It is the first revocation of a biopatent since the introduction of the newly revised EU regulation for biopatents in 2017.

read more
Kontakt / Contact
close slider
Um dieses Angebot nutzen zu können, müssen Sie der Speicherung Ihrer personenbezogenen Daten zustimmen. Wir behandeln diese streng vertraulich und verwenden sie nur zur Kontaktaufnahme mit Ihnen. Mehr dazu lesen Sie in unserer Datenschutz-Erklärung.
Das System verwendet Cookies, die uns eine Nutzeranalyse unserer Website ermöglichen.